195 related articles for article (PubMed ID: 15323137)
1. Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.
Willmore C; Holden JA; Zhou L; Tripp S; Wittwer CT; Layfield LJ
Am J Clin Pathol; 2004 Aug; 122(2):206-16. PubMed ID: 15323137
[TBL] [Abstract][Full Text] [Related]
2. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
3. High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors.
Holden JA; Willmore-Payne C; Coppola D; Garrett CR; Layfield LJ
Am J Clin Pathol; 2007 Aug; 128(2):230-8. PubMed ID: 17638656
[TBL] [Abstract][Full Text] [Related]
4. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
[TBL] [Abstract][Full Text] [Related]
6. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens.
Willmore-Payne C; Layfield LJ; Holden JA
Cancer; 2005 Jun; 105(3):165-70. PubMed ID: 15822120
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
9. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
Bernet L; Zuñiga A; Cano R
Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
[TBL] [Abstract][Full Text] [Related]
10. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
11. Microfluidic deletion/insertion analysis for rapid screening of KIT and PDGFRA mutations in CD117-positive gastrointestinal stromal tumors: diagnostic applications and report of a new KIT mutation.
Zamò A; Bertolaso A; Franceschetti I; Weirich G; Capelli P; Pecori S; Chilosi M; Hoefler H; Menestrina F; Scarpa A
J Mol Diagn; 2007 Apr; 9(2):151-7. PubMed ID: 17384206
[TBL] [Abstract][Full Text] [Related]
12. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.
Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF
Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
14. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y
J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524
[TBL] [Abstract][Full Text] [Related]
15. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA
Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439
[TBL] [Abstract][Full Text] [Related]
16. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
17. KIT exon 11 deletion-inversions represent complex mutations in gastrointestinal stromal tumors.
Lasota J; Miettinen M
Cancer Genet Cytogenet; 2007 May; 175(1):69-72. PubMed ID: 17498562
[TBL] [Abstract][Full Text] [Related]
18. Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors.
Agaram NP; Baren A; Arkun K; Dematteo RP; Besmer P; Antonescu CR
Ultrastruct Pathol; 2006; 30(6):443-52. PubMed ID: 17182437
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of c-kit gene mutations in gastrointestinal stromal tumors].
Hou YY; Sun MH; Tan YS; Wei YK; Lu XY; Zhang TM; Du X; Wang J; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):89-92. PubMed ID: 15059325
[TBL] [Abstract][Full Text] [Related]
20. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
